Literature DB >> 14615832

Testicular ischemia due to intravascular large B-cell lymphoma: a novel presentation in an immunosuppressed individual.

Paul Tranchida1, Michael Bayerl, Mary Jo Voelpel, Margarita Palutke.   

Abstract

A 56-year-old man presented with fever, disorientation, and testicular pain. He was receiving azathioprine immunosuppression for autoimmune hepatitis. Orchiectomy identified occlusion of spermatic cord vessels by intravascular large B-cell lymphoma (IVLBL) and ischemic changes in the testis. Tumor cells were positive for CD 10, CD 20, CD 30, and Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) and early region RNA (EBER). He was treated with the cessation of azathioprine, chemotherapy, anti-CD 20 immunotherapy, and radiotherapy. Twenty months after diagnosis, he is alive with no evidence of lymphoma or hepatitis. This is the first report of IVLBL presenting with testicular ischemia. It highlights the importance of prompt diagnosis and intervention to achieve durable response. That this lymphoma arose in the setting of immunosuppressive therapy introduces additional complexity relating to pathogenesis, clinical behavior, and treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615832     DOI: 10.1177/106689690301100414

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

Review 1.  Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids.

Authors:  Marta Casal Moura; Rodrigo Liberal; Hélder Cardoso; Ana Maria Horta E Vale; Guilherme Macedo
Journal:  World J Hepatol       Date:  2014-06-27

2.  EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.

Authors:  Luis Veloza; Chun-Yi Tsai; Bettina Bisig; Olivier Pantet; Lorenzo Alberio; Christine Sempoux; Matthias Cavassini; Laurence de Leval
Journal:  Virchows Arch       Date:  2021-06-19       Impact factor: 4.535

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.